Most people probably know that cancer occurs when cells of the body grow out of control. But what they may not know is that cancers are generally described by the location from which they originated. So, in the case of breast cancer, the tumor starts in breast tissue, such as the milk-producing glands, called lobules, or in the ducts that transport milk from the lobules to the nipple. If that cancer spreads to another body part, such as a lymph node or bone, it is called metastatic, and it is still considered breast cancer.1,2
What even fewer people may know is that there are 4 main subtypes of breast cancer.3 These are based on the presence or absence of receptors on the cancer’s cell surface and are involved in how the cancer grows.4-6 The severity of each type varies, but all of them have the potential to become metastatic. 5,6
The cancerous cells that form in breast tissue may contain proteins that function as hormone receptors (HRs) for estrogen or progesterone, and if they do, those hormones can fuel cell growth.5 As its name suggests, human epidermal growth factor receptor 2 (HER2/neu) is another protein involved in normal cell growth, and it can be produced in larger-than-normal amounts in breast cancer.6
One of the first things a doctor does when investigating someone’s breast cancer is to determine whether or not these receptors are present in the cancerous cells. That receptor status provides insight into how the cancer can be expected to behave, and perhaps most importantly, how it may respond to treatment.5,6 Receptor status is a big deal.
Such a big deal, in fact, that the presence or absence of these receptors can describe more than 90% of the different types of breast cancer. Doctors break that down into 4 main groups*3,4:
(The remaining ~7% comprises various forms that are very uncommon.)
*Percentage is for females. Based on data from cases in 2014-2018.4
Why is it so important to understand what type of breast cancer you have? Because of the complexities and nuances between subtypes, your doctor will develop a treatment plan specific to your receptor status.5,6
Let’s zoom out and look at mBC from a big-picture vantage point.
There are so many people in the country living with MBC that they could form a mid-sized city. Of the ~280,000 people diagnosed with breast cancer each year,8 about 6% will be metastatic at the time of diagnosis, and up to 30% of cases could eventually become metastatic.7
Notice that we’ve cited those numbers as people, and not women. While breast cancer affects primarily females, males can, in fact, get it. Men account for 1% of breast cancer cases and 1% of breast cancer deaths.9 The breast cancers that men get are often metastatic.10 mBC rates vary by race as well: African American women are more likely to be diagnosed than Americans of European ancestry and are 40% more likely to die from the disease.11 The racial disparity is particularly noticeable in younger women.11 Regardless of race, mBC is most often diagnosed between the ages of 45 and 65.12
Some researchers have estimated that ~80,000 people are diagnosed with metastatic breast cancer annually, though concrete numbers aren’t available.13 One number, however, is painfully certain: approximately 40,000 Americans die from mBC annually.8
If you or someone close to you was recently diagnosed with mBC, you’re not alone. Many others have gone through a similar experience, some of whom eagerly share guidance and support. You can find a curated list of great advocacy and support groups here: https://www.halaven.com/metastatic-breast-cancer/community-groups.
There is reason for optimism: the survival rate is rising. Greater awareness and improvements in treatment have helped more women live longer following their mBC diagnosis.14 One can hope that the trend continues, and the women diagnosed today will live even longer.
It’s important to remember that these types of statistics provide an overview for the general population. An individual’s risk can vary for a wide range of factors, including age of diagnosis, ethnicity, cancer subtype, and more.14 These figures are helpful in understanding the disease in broad terms; they shouldn’t be misconstrued as a prediction of how long any individual may live after being diagnosed with mBC.
mBC may be more common than you realize. It certainly warrants more awareness, given its severity. It’s also important to remember that on the other side of all the statistics the lives of real people are being affected every day. For every diagnosis, there is a family dealing with uncertainties and worries. One of the best ways to overcome those uncertainties is through education. If you’d like to learn more about mBC, please visit https://www.halaven.com/metastatic-breast-cancer/what-is-mbc.
Learn 3 key facts that everyone may not know about metastatic breast cancer—but should. Read More
Destroying cancer cells with…a sea sponge? Read about the wild science behind the active ingredient in HALAVEN (eribulin mesylate). Read More
Getting ready for your HALAVEN infusion? These tips may help you prepare for a low-stress experience. Read More
HALAVEN is a prescription medicine used to treat adults with breast cancer that has spread to other parts of the body, and who have already received other types of anticancer medicines after the cancer has spread.
HALAVEN can cause serious side effects, including
Before you receive HALAVEN, tell your health care provider about all of your medical conditions, including if you
Tell your health care provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
What are the possible side effects of HALAVEN?
HALAVEN can cause changes in your heartbeat (called QT prolongation). This can cause irregular heartbeats. Your health care provider may do heart monitoring (electrocardiogram or ECG) or blood tests during your treatment with HALAVEN to check for heart problems.
The most common side effects of HALAVEN in adults with breast cancer include low white blood cell count (neutropenia), low red blood cell count (anemia), weakness or tiredness, hair loss (alopecia), nausea, and constipation.
Your health care provider will do blood tests before and during treatment while you are taking HALAVEN.
For more information about HALAVEN, please see full Prescribing Information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.